Assessing a measure for Quality of Life in patients with severe Alopecia Areata: a multicentric Italian study.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Caldarola Giacomo, Raimondi Giulia, Samela Tonia, Pinto Lorenzo, Pampaloni Francesca, Starace Michela Valeria Rita, Diluvio Laura, Dall'Oglio Federica, Vagnozzi Emanuele, de Felici Del Giudice Maria Beatrice, Balestri Riccardo, Ambrogio Francesca, Girolomoni Giampiero, Riva Silvia Francesca, Moro Francesco, Atzori Laura, Gallo Giuseppe, Ribero Simone, Simonetti Oriana, Barruscotti Stefania, Boccaletti Valeria, Marzano Angelo Valerio, Bianchi Luca, Micali Giuseppe, Piraccini Bianca Maria, Fargnoli Maria Concetta, Abeni Damiano, Peris Ketty
Аннотация
METHODS: This is a longitudinal, multicenter, observational study. Patients returned for follow-up visits at 4-, 12-, and 24-weeks. The analyses of the current work aimed to confirm the factorial structure of the Skindex-16AA. In the case of non-fit, an alternative structure for the model was proposed, using an Exploratory Graph Analysis and the Bayesian approach.
RESULTS: The sample was composed of 106 patients with AA. Alopecia Universalis was the most frequently diagnosed type of alopecia at all time points. The analyses on the Skindex-16AA revealed that a two-factor structure with eight items fit the data best (Bayesian Posterior Predictive Checking using 95% Confidence Interval for the Difference Between the Observed and the Replicated Chi-Square values = -6.246/56.395, Posterior Predictive P-value = 0.06), and reported satisfactory psychometric properties (i.e., internal consistency and convergent validity).
CONCLUSION: The Skindex-8AA demonstrated optimal psychometric properties (i.e., convergent and construct validity, and test-retest reliability) measured in a sample of patients with AA, that may suggest that it is an appropriate tool to measure the HRQoL in AA patients. However, further studies are needed in order to confirm and tested other psychometric features of this tool.